Examination Of Exercise Adherence İn Lung Cancer Patients Given Calisthenic Exercise
NCT ID: NCT05332171
Last Updated: 2022-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2022-04-30
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCER
NCT07237503
The Relationships Between Physical Activity Level, Quality of Life and Cognitive Level in Breast Cancer Patients
NCT05275517
Fit for Everyday Life - Increasing Exercise and Physical Activity in Those Rehablilitating From Cancer
NCT05403671
How to Carry on an Effective Community Program of Exercice-oncology.
NCT05078216
Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience
NCT03724331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Within the scope of the study, exercise compliance will be examined in patients with lung cancer who are given calisthenic exercise.
Participants will be evaluated before treatment, their functional capacities will be determined, their compliance with exercise, fatigue levels, pain levels, cognitive status, sleep and quality of life will be evaluated with questionnaires.
Home exercises will be taught to the physical activity counseling group and will be followed up under the supervision of a physiotherapist with weekly controls. Breathing exercises and calisthenic exercises will be taught to the training group, and participants will be followed under the supervision of a physiotherapist for 8 weeks, 3 days a week. Evaluations will be made before and after the treatment.
Individuals who do not agree to / give up participating in the study will be able to leave the study voluntarily.
All information belonging to individuals will be protected according to the personal data protection law.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Criteria for inclusion in the study;
* Patients whose chemotherapy and radiotherapy has ended, at least 6 months and maximum 5 years after surgery
* Being between the ages of 18-65
* 3 and 5 years according to the Modified Borg Scale Patients with severe fatigue Exclusion criteria;
* Uncontrollable hypertension, diabetes mellitus, heart failure and atrial fibrillation
* Any acute infection during the evaluation
* Orthopedic, neurological, psychological, etc., which will limit the evaluations. with problems
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
physical activity counseling
Home exercises will be taught to the physical activity counseling group and will be followed up under the supervision of a physiotherapist with weekly controls. Evaluation will be done before and after treatment.
No interventions assigned to this group
training group
Breathing exercises and calisthenic exercises will be taught to the training group, and they will be followed under the supervision of a physiotherapist for 8 weeks, 3 days a week. Evaluations will be made before and after treatment. Individuals in the calisthenic exercise group will be given exercise training at the level of 65%-80% of the maximal heart rate for 30-40 minutes, 3 days a week for 8 weeks.
Pyhsiohterapy and rehabilitation
Before starting the exercise program, 10 repetitive warm-up exercises will be given including the lower and upper extremities and distal joints. The exercises will be started with 5 repetitions in the first week. Depending on the patient's tolerance, the intensity of the exercise will be increased as 10 repetitions, 15 repetitions and 20 repetitions, and optional rest will be allowed between exercises. It is aimed that the patients reach 20 repetitions in the 6th week at the latest.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pyhsiohterapy and rehabilitation
Before starting the exercise program, 10 repetitive warm-up exercises will be given including the lower and upper extremities and distal joints. The exercises will be started with 5 repetitions in the first week. Depending on the patient's tolerance, the intensity of the exercise will be increased as 10 repetitions, 15 repetitions and 20 repetitions, and optional rest will be allowed between exercises. It is aimed that the patients reach 20 repetitions in the 6th week at the latest.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being between the ages of 18-65
* 3 and 5 years according to the Modified Borg Scale Patients with severe fatigue
Exclusion Criteria
* Any acute infection during the evaluation
* Orthopedic, neurological, psychological, etc., which will limit the evaluations. with problems
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasan Kalyoncu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kardelen HATIMOĞULLARI
physiotherapist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasan Kalyoncu Univercity
Gaziantep, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.